CNBT
ALXN

Cornerstone National Bank & Trust’s Alexion Pharmaceuticals ALXN Stock Holding History

Cornerstone National Bank & Trust’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,434
Closed -$831K – 62
2021
Q1 		$831K Sell
5,434
-1,049
-16% -$162K 0.39% 33
2020
Q4 		$1.01M Sell
6,483
-948
-13% -$122K 0.55% 27
2020
Q3 		$850K Sell
7,431
-839,981
-99% -$90.6M 0.54% 28
2020
Q2 		$847K Buy
847,412
+839,676
+10,854% +$89.1M 0.62% 26
2020
Q1 		$695K Buy
7,736
+956
+14% +$93.8K 0.63% 31
2019
Q4 		$733K Buy
+6,780
New +$725K 0.66% 39

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Cornerstone National Bank & Trust's ALXN Position: Q2 2021 in Review

Cornerstone National Bank & Trust sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 5,434 shares — an estimated $831K sold.

Cornerstone National Bank & Trust first reported a position in ALXN in Q4 2019 and held it in 6 quarters. The position peaked at $1.01M in Q4 2020. 707 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • Cornerstone National Bank & Trust reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Cornerstone National Bank & Trust sold 5,434 Alexion Pharmaceuticals shares in Q2 2021, an estimated $831K.
  • Cornerstone National Bank & Trust first reported a position in Alexion Pharmaceuticals in Q4 2019 and held it in 6 quarters.
  • Cornerstone National Bank & Trust's Alexion Pharmaceuticals position peaked at $1.01M in Q4 2020.
  • 707 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on Cornerstone National Bank & Trust's 13F filing for Q2 2021, filed 28 Jan 2026.